• Wednesday, 26 June 2019

Prospering Cannabis Companies Attract a Growing Workforce


May 17, 2019 (1 month ago) |
NEW YORK: Around the world, different countries have needs for different professions. For instance, the U.S. is seeing a growing demand for application software developers, medical service managers, registered nurses, and construction laborers.
The demand for those specific job fields is high, but it does not necessarily mean that employers will hire those who do not meet stringent criteria. The U.S. economy created a total of 2.7 million jobs in 2018, nevertheless, those specific fields are still lacking adequate employment. The tightening job market and increasing demand for experience and qualifications have made job searching difficult for those seeking employment. On the other hand, the cannabis industry is thriving and according to a report by Leafly and Whitney Economics, the cannabis industry totaled 211,000 jobs at the end of 2018. However, cannabis-related job additions are not included in the Bureau of Labor Statistics because the plant remains classified as a Schedule 1 drug at the federal level, meaning that the overall U.S. job count could be significantly higher if cannabis-related employment was included. As legalization continues to accelerate in the U.S., more jobs are expected to be created to meet the ever-growing consumer demand. According to data compiled by Grand View Research, the global legal marijuana market is expected to reach USD 146.4 Billion by 2025. Furthermore, the market is projected to register a CAGR of 34.6% during the forecast period. Blueberries Medical Corp. (OTC BBRRF) (CSE BBM), PharmaCielo Ltd. (OTC PHCEF) (TSX-V PCLO), Khiron Life Sciences Corp. (OTC KHRNF) (TSX-V KHRN), Abbott Laboratories (NYSE ABT), Arcadia Biosciences, Inc. (NASDAQ RKDA)

The report highlighted that job growth increased from 21% in 2017 to 44% in 2018 within the U.S. While the U.S. market accounts for a majority of the global cannabis market share, other countries are swiftly moving towards adopting cannabis legislation as well. The U.S. is the largest recreational market, which means that jobs such as budtenders and retail operators are available. Moreover, jobs such as distributors and cultivators will be in demand as they will be able to both grow and distribute the product within the same country, depending on licensing and regulatory agreements. Specifically, the Latin American region is seeing an increasing demand for jobs related to the cannabis industry as companies are attracted to the LATAM region because of its cheaper operation costs when opposed to North American or Europen markets. Cultivation and distribution jobs are also growing within the region to meet the demand of potentially 4.6 million patients by 2028, according to Prohibition Partners. Countries such as Colombia, Chile, and Uruguay are especially expected to thrive in the accelerating cannabis industry. As the cannabis industry becomes more legitimate, more and more professional roles will be in demand to help businesses comply with tax laws and regulations and scale into larger markets, according to a report by Glassdoor.

Blueberries Medical Corp. (OTCQB BBRRF) (CSE BBM) is also listed on the Canadian Securities Exchange under the ticker (CSE BBM). Earlier this month, the Company announced the, appointment of Eduardo Molinari, a former executive of Abbott Laboratories (NYSE ABT) (Abbott) and AbbVie Ltd. (NYSE ABBV) (AbbVie) as Chief Marketing Officer. Mr. Molinari will lead the development and implementation of the Company's marketing strategies, directing these initiatives in the local and international markets.

Dr Patricio Stocker, Chief Executive Officer of the Company stated, We are proud to welcome Mr. Molinari to our management team. Eduardo is a highly successful pharmaceutical industry executive as most recently demonstrated through his development of very successful marketing strategies at Abbott and AbbVie in Latin America. This experience along with his deep relationships will be a tremendous asset for us. Blueberries will continue to add world-class senior executives to its management team in an effort to capture a leadership share of the Latin American and international medical cannabis industry.

Mr. Molinari stated I am excited to join Blueberries as the company continues to execute on their unique business model. The combination of world-class management, strategic Latin American facilities and global partnerships presents a very compelling opportunity. I'm eager to leverage my experience and relationships to contribute to the company's long-term success in the international marketplace.

Mr. Molinari has more than 25 years of experience in the pharmaceutical industry, having held executive leadership positions in countries across Latin America, most recently VP Region North - Latin America of AbbVie until December 2018. In 2012, when Abbott spun out it's pharmaceutical business to form AbbVie, Mr. Molinari left Abbott to establish AbbVie in Latin America where he played a key role in the growth of the company in the region. His business expertise is combined with deep experience in R&D both in academia at Northwestern University Medical School in Chicago and in the pharmaceutical industry. Mr. Molinari has shown continued growth as a leader in the industry with a commitment to bringing healthcare solutions to patients globally.

Mr. Molinari has been granted options (the 'Options') to purchase up to 200,000 common shares in the capital of the Company, pursuant to the Company's stock option plan. The Options are exercisable at a price of $0.75 per share.

About Blueberries Medical Corp Blueberries is a Latin American licensed producer of naturally grown premium quality cannabis with its primary operations ideally located in the Bogota Savannah of central Colombia and operations currently being established in Argentina. The Company is led by a specialized team with proprietary expertise in agriculture, genetics, extraction, medicine, pharmacology and marketing, Blueberries is fully licensed for the cultivation, production, domestic distribution, and international export of CBD and THC-based medical cannabis in Colombia. Blueberries' combination of leading scientific expertise, agricultural advantages and distribution arrangements has positioned the Company to become a leading international supplier of naturally grown, processed, and standardized medicinal-grade cannabis oil extracts and related products.

Like This Article?
Prospering Cannabis Companies Attract a Growing Workforce

contact Post your comment

category Read other United States News stories

home page Visit Home Page for latest updates